Open AccessImaging of pulmonary hypertension: an update
Author(s) -
Harold Goerne,
Kiran Batra,
Prabhakar Rajiah
Publication year - 2018
Publication title -
cardiovascular diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 22
eISSN - 2223-3660
pISSN - 2223-3652
DOI - 10.21037/cdt.2018.01.10
Subject(s) - medicine , pulmonary hypertension , magnetic resonance imaging , radiology , pulmonary vasculature , etiology , modalities , broad spectrum , angiography , pulmonary angiography , social science , chemistry , sociology , combinatorial chemistry
Pulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure caused by a broad spectrum of congenital and acquired disease processes, which are currently divided into five groups based on the 2013 WHO classification. Imaging plays an important role in the evaluation and management of PH, including diagnosis, establishing etiology, quantification, prognostication and assessment of response to therapy. Multiple imaging modalities are available, including radiographs, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, echocardiography and invasive catheter angiography (ICA), each with their own advantages and disadvantages. In this article, we review the comprehensive role of imaging in the evaluation of PH.